Challenge to Grant Review Process Sought by OMB-2026-0034
METAvivor submitted a formal response to OMB-2026-0034 opposing proposed changes to federal research funding. METAvivor submitted a formal response to the Office of Management and Budget regarding the proposed Uniform […]
Support Legislation Removing Barriers to Clinical Trials
METAvivor signed onto a letter supporting the Clinical Trial Modernization Act. METAvivor has joined nearly 200 patient advocacy, public health, and health care organizations in supporting the bipartisan Clinical Trial […]
Letter from Alliance for Breast Cancer Policy
METAvivor Leads the Call for Better Cancer Registry Data As a proud Steering Committee member of the Alliance for Breast Cancer Policy, METAvivor was proud to sign on to this […]
Investing in Hope: Congratulations to the 2025 METAvivor Research Grant Awardees
Funding research has been at the core of METAvivor’s mission since its founding in 2009. Our all-volunteer Board of Directors, most of whom are living with metastatic breast cancer (MBC), […]
Together for Hope: METAvivor x Ageless Zen
BY Kelly Shanahan, M.D. “As a mom, as a doctor, and now as an advocate for and a person living with metastatic breast cancer, I’ve never really been good about […]
Letter from METAvivor’s Director of Research
BY Kelly Shanahan, M.D. METAvivor President and Director of Research METAvivor’s core mission is to fund research that will benefit those of us whose cancer has already metastasized. We are […]
Perspective of a Breast Cancer Researcher in a Rapidly Degenerating Funding and Support Landscape
BY Gloria Echeverria, PhD Feb 25, 2025 Note: These views are my own and do not necessarily represent those of my current employer, Baylor College of Medicine, my prior employer […]
Welcome Our New Executive Committee!
METAvivor is excited to announce the newest additions to our Executive Committee, who bring a wealth of expertise, passion, and commitment to advancing our mission. Each member shares our dedication […]